By Dr Meg Limited 09806756 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is that of medical consultancy. Digita Accounts Production Advanced 6.30.9574.0 true 09806756 2025-01-01 2025-12-31 09806756 2025-12-31 09806756 core:CurrentFinancialInstruments 2025-12-31 09806756 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 09806756 core:OfficeEquipment 2025-12-31 09806756 core:PlantMachinery 2025-12-31 09806756 bus:SmallEntities 2025-01-01 2025-12-31 09806756 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 09806756 bus:FilletedAccounts 2025-01-01 2025-12-31 09806756 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 09806756 bus:RegisteredOffice 2025-01-01 2025-12-31 09806756 bus:Director2 2025-01-01 2025-12-31 09806756 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09806756 core:OfficeEquipment 2025-01-01 2025-12-31 09806756 core:PlantMachinery 2025-01-01 2025-12-31 09806756 core:VehiclesPlantMachinery 2025-01-01 2025-12-31 09806756 core:OtherRelatedParties 2025-01-01 2025-12-31 09806756 countries:EnglandWales 2025-01-01 2025-12-31 09806756 2024-12-31 09806756 core:OfficeEquipment 2024-12-31 09806756 core:PlantMachinery 2024-12-31 09806756 2024-01-01 2024-12-31 09806756 2024-12-31 09806756 core:CurrentFinancialInstruments 2024-12-31 09806756 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09806756 core:OfficeEquipment 2024-12-31 09806756 core:PlantMachinery 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 09806756

By Dr Meg Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 December 2025

By Dr Meg Limited

Contents

Balance Sheet | 1 to 2
Notes to the Unaudited Financial Statements | 3 to 6

By Dr Meg Limited

(Registration number: 09806756)
Balance Sheet as at 31 December 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | - | 59,178
Current assets |  |  |
Debtors | 5 | 48,932 | 290
Cash at bank and in hand |  | 20,235 | 6,136
|  | 69,167 | 6,426
Creditors: Amounts falling due within one year | 6 | (108,107) | (210,553)
Net current liabilities |  | (38,940) | (204,127)
Net liabilities |  | (38,940) | (144,949)
Capital and reserves |  |  |
Called up share capital |  | 100 | 100
Retained earnings |  | (39,040) | (145,049)
Shareholders' deficit |  | (38,940) | (144,949)

By Dr Meg Limited

(Registration number: 09806756)
Balance Sheet as at 31 December 2025

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 March 2026 and signed on its behalf by:

......................................... M Cope Director

By Dr Meg Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of discounts and rebates.

By Dr Meg Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Tax

The tax expense for the period comprises current tax payable.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Office equipment | 25% straight line basis
Plant and Machinery | 25% straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

By Dr Meg Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

4 | Tangible assets

| Plant and machinery £ | Office equipment £ | Total £
Cost or valuation
At 1 January 2025 | 88,617 | 4,767 | 93,384
Disposals | (88,617) | - | (88,617)
At 31 December 2025 | - | 4,767 | 4,767
Depreciation
At 1 January 2025 | 29,540 | 4,666 | 34,206
Charge for the year | 22,152 | 101 | 22,253
Eliminated on disposal | (51,692) | - | (51,692)
At 31 December 2025 | - | 4,767 | 4,767
Carrying amount
At 31 December 2025 | - | - | -
At 31 December 2024 | 59,077 | 101 | 59,178

5 | Debtors

Current | 2025 £ | 2024 £
Prepayments | - | 290
Other debtors | 48,932 | -
| 48,932 | 290

By Dr Meg Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

6 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 7 | 85,000 | 128,500
Trade creditors |  | - | 644
Taxation and social security |  | 21,247 | 7,003
Other creditors |  | 1,860 | 74,406
|  | 108,107 | 210,553

7 | Loans and borrowings

Current loans and borrowings

| 2025 £ | 2024 £
Other borrowings | 85,000 | 128,500

8 | Related party transactions

Other transactions with directors

Summary of transactions with other related parties

During the year the company made the following related party transactions:
By Dr Meg Limited raised sales invoices during the year to The MW Clinic Limited; a company of which M C
Cope is also a director . The total value of sales in the period was £157,944 (2024: £86,500). At the balance
sheet date the amount owed from The MW Clinic Limited is £nil (2024: £nil).
M C Cope, a director, has a loan with the company. The amount owed to M C Cope at the balance sheet date
was £(60) (2024: £72,661).
By Dr Meg Limited was in receipt of a loan from D Cope, a shareholder of the company. At the balance sheet
date the amount owed to D Cope was £85,000 (2024 : £123,500).